Trials / Terminated
TerminatedNCT05370209
Performance and Safety of Otinova® Ear Spray
A Prospective, Post-Market Clinical Follow-up Investigation to Verify Performance and Safety of Otinova® Ear Spray When Used in the Treatment of External Otitis Symptoms
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Circius Pharma AB · Industry
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the performance and safety of Otinova® Ear Spray when used in the treatment of external otitis symptoms.
Detailed description
After being informed about the study and potential risks, all patients giving written informed consent will receive treatment with Otinova® Ear Spray for 7 days, twice daily.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Otinova® Ear Spray | Ear spray |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2023-11-27
- Completion
- 2024-01-29
- First posted
- 2022-05-11
- Last updated
- 2024-11-15
- Results posted
- 2024-11-15
Locations
3 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT05370209. Inclusion in this directory is not an endorsement.